Kybella generated a lot of buzz when it was approved in 2015 as an injectable treatment for double chins. What do physicians have to say about it three years later?
What will shape cosmetic medicine in 2018? We asked industry leaders to weigh in with what they think will drive aesthetic medicine’s evolution this year.
A plastic surgery taskforce recently released recommendations for gluteal fat grafting, a procedure that has a significantly higher mortality rate than any other in the aesthetic space.
While non-surgical fat reduction technologies can yield dramatic results, stubborn and residual swelling often remains present in the treated areas. This is where the Z Wave from Zimmer MedizinSystems (Irvine, Calif.) comes in. Using radial pulse energy, the Z Wave device enhances the outcome of cryolipolysis treatments by transmitting high-energy acoustic waves through soft tissue, which spread radially beneath the skin’s surface.
The non-invasive body contouring device SculpSure has added submental to its FDA clearance areas, including abdomen, love handles, back and thighs.
Still wondering if you should add Cellfina to your practice? One plastic surgeon details his first year of experience.
After failing phase III trial in 2016, this injectable fat dissolver is back in a proof of concept study for treating the double chin.
Syneron Medical announced in mid-July FDA clearance of its noninvasive UltraShape Power device for fat reduction around the abdomen.
Body contouring is already one of the fastest growing segments in aesthetic medicine, and it’s only getting stronger.
One expert reveals what he calls the “winning” nonsurgical devices of 2016 for skin tightening, fat reduction and hair grafting. » Learn More